Media stories about Motif Bio (NASDAQ:MTFB) have trended somewhat positive recently, according to Accern. Accern rates the sentiment of news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Motif Bio earned a media sentiment score of 0.18 on Accern’s scale. Accern also gave press coverage about the company an impact score of 44.7540307049352 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.
Motif Bio (MTFB) opened at $9.51 on Thursday. Motif Bio has a 1-year low of $5.36 and a 1-year high of $13.75.
Separately, HC Wainwright set a $32.00 price target on Motif Bio and gave the company a “buy” rating in a report on Wednesday, October 11th.
Receive News & Ratings for Motif Bio plc - Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motif Bio plc - and related companies with MarketBeat.com's FREE daily email newsletter.